We are live on ! Find out more
ID

Integral Derivatives Portfolio holdings

AUM $4.07B
1-Year Est. Return 19.81%
This Fund
S&P 500
This Quarter Est. Return
+5.14%
1 Year Est. Return
+19.81%
3 Year Est. Return
+45.77%
5 Year Est. Return
10 Year Est. Return
AUM
$5.09B
AUM Growth
-$414M
Cap. Flow
-$82.8M
Cap. Flow %
-1.63%
Top 10 Hldgs %
56.63%
Holding
1,386
New
277
Increased
357
Reduced
419
Closed
288

Sector Composition

Rank Sector Weight
1 Miscellaneous 95.35%
2 Communication Services 1.13%
3 Technology 1.09%
4 Consumer Discretionary 0.51%
5 Energy 0.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
251
Visa
V
$709B
$2.38M 0.05%
20,849
+14,339
+220% +$1.58M
ADBE icon
252
CALL
Adobe
ADBE
$115B
$2.37M 0.05%
13,500
+1,200
+10% +$206K
FSLR icon
253
PUT
First Solar
FSLR
$22.6B
$2.36M 0.05%
35,000
-4,800
-12% -$282K
AU icon
254
PUT
AngloGold Ashanti
AU
$59.9B
$2.36M 0.05%
231,500
+127,100
+122% +$1.23M
KBE icon
255
PUT
State Street SPDR S&P Bank ETF
KBE
$1.69B
$2.35M 0.05%
49,600
MA icon
256
Mastercard
MA
$518B
$2.35M 0.05%
15,513
+1,200
+8% +$178K
BRK.B icon
257
PUT
Berkshire Hathaway Class B
BRK.B
$1.08T
$2.34M 0.05%
11,800
+5,400
+84% +$1.03M
ISRG icon
258
CALL
Intuitive Surgical
ISRG
$130B
$2.34M 0.05%
19,200
+16,500
+611% +$2.06M
SLV icon
259
CALL
iShares Silver Trust
SLV
$33.8B
$2.32M 0.05%
145,100
+103,400
+248% +$1.63M
JNJ icon
260
CALL
Johnson & Johnson
JNJ
$640B
$2.31M 0.05%
16,500
-18,800
-53% -$2.62M
ELV icon
261
PUT
Elevance Health
ELV
$86.6B
$2.29M 0.05%
10,200
-300
-3% -$63.9K
GIS icon
262
PUT
General Mills
GIS
$21.6B
$2.29M 0.05%
38,700
+16,200
+72% +$876K
MON
263
CALL
DELISTED
Monsanto Co
MON
$2.28M 0.04%
19,500
+14,100
+261% +$1.68M
TEVA icon
264
CALL
Teva Pharmaceuticals
TEVA
$43.8B
$2.23M 0.04%
117,400
+34,900
+42% +$525K
REGN icon
265
PUT
Regeneron Pharmaceuticals
REGN
$83.2B
$2.22M 0.04%
5,900
-200
-3% -$81K
BKNG icon
266
Booking.com
BKNG
$152B
$2.21M 0.04%
31,775
-17,350
-35% -$1.26M
T icon
267
AT&T
T
$174B
$2.21M 0.04%
75,219
-180,521
-71% -$4.93M
MDT icon
268
CALL
Medtronic
MDT
$115B
$2.2M 0.04%
27,300
+13,800
+102% +$1.11M
PX
269
PUT
DELISTED
Praxair Inc
PX
$2.2M 0.04%
14,200
-5,900
-29% -$875K
GDXJ icon
270
PUT
VanEck Junior Gold Miners ETF
GDXJ
$9.92B
$2.19M 0.04%
64,200
+51,000
+386% +$1.66M
MRO
271
PUT
DELISTED
Marathon Oil Corporation
MRO
$2.19M 0.04%
129,200
+2,300
+2% +$34.2K
WYNN icon
272
PUT
Wynn Resorts
WYNN
$9.64B
$2.17M 0.04%
12,900
+6,700
+108% +$1.03M
MRK icon
273
CALL
Merck
MRK
$369B
$2.17M 0.04%
40,453
+8,908
+28% +$494K
XLV icon
274
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44.6B
$2.17M 0.04%
26,200
+10,100
+63% +$833K
AFL icon
275
CALL
Aflac
AFL
$58.4B
$2.16M 0.04%
+49,200
New +$2.1M

Similar funds

Integral Derivatives's Q4 2017 Portfolio in Review

As of Q4 2017, Integral Derivatives held 1,386 positions worth $5.09B, down 7.5% from $5.5B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Integral Derivatives's Q4 2017 filing shows 277 new, 357 increased, 419 reduced and 288 closed positions. Its largest new stake was Union Pacific: 88,239 shares worth $11.8M. The largest sale was Apple, an estimated $18.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 95% of assets, up from 95% a quarter earlier, followed by Communication Services and Technology.

  • Integral Derivatives's largest Q4 2017 buy was Union Pacific: 88,239 shares worth $11.8M.
  • Integral Derivatives added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $12.2M increase.
  • Integral Derivatives's biggest Q4 2017 reduction was State Street SPDR S&P Oil & Gas Exploration & Production ETF, cutting an estimated $6.55M.
  • Integral Derivatives fully exited Apple in Q4 2017, selling an estimated $18.5M.
  • Integral Derivatives's ten largest holdings make up 57% of its $5.09B portfolio in Q4 2017.
  • Integral Derivatives opened 277 new positions and closed 288 in Q4 2017.
  • Integral Derivatives's portfolio value fell 7.5% quarter-over-quarter to $5.09B.

Based on Integral Derivatives's 13F filing for Q4 2017, filed 14 Feb 2018.